{"disease":{"id":"bacterial-skin-disease","name":"bacterial skin disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03716024","title":"Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Paratek Pharmaceuticals Inc","has_results":true},{"nct_id":"NCT04485676","title":"Dalbavancin in Real Clinical Practice in Spain","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Angelini Farmacéutica","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}